BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32516415)

  • 1. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.
    Schoettler M; Lehmann LE; Margossian S; Lee M; Kean LS; Kao PC; Ma C; Duncan CN
    Blood Adv; 2020 Jun; 4(11):2536-2547. PubMed ID: 32516415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
    Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
    Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors.
    Sadowska-Klasa A; Dukat-Mazurek A; Zielińska H; Dębska-Zielkowska J; Piekarska A; Moszkowska G; Mensah-Glanowska P; Zaucha JM
    Transplant Cell Ther; 2024 Jan; 30(1):99.e1-99.e10. PubMed ID: 37875214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
    Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J; Hammers YA; Rytting H; Williams KM
    Transplant Cell Ther; 2023 Jan; 29(1):45.e1-45.e8. PubMed ID: 36202334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy.
    Sagou K; Fukushima N; Ukai S; Goto M; Ozeki K; Kohno A
    Int J Hematol; 2020 Nov; 112(5):697-706. PubMed ID: 32748214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT.
    Elfeky R; Lucchini G; Lum SH; Ottaviano G; Builes N; Nademi Z; Battersby A; Flood T; Owens S; Cant AJ; Young H; Greener S; Walsh P; Kavanagh D; Annavarapu S; Rao K; Amrolia P; Chiesa R; Worth A; Booth C; Skinner R; Doncheva B; Standing J; Gennery AR; Qasim W; Slatter M; Veys P
    Blood Adv; 2020 Jun; 4(11):2418-2429. PubMed ID: 32492158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
    Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
    Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
    Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B; Stenger E; Qayed M; Chonat S; Westbrook A; Switchenko J; Williams KM
    Am J Hematol; 2024 Mar; 99(3):370-379. PubMed ID: 38164997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
    Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
    Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
    Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
    Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
    Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
    Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis.
    Guo M; Qi J; Hou Q; Li X; Han Y
    Expert Rev Hematol; 2023 Mar; 16(3):191-203. PubMed ID: 36588482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
    Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
    Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
    Benítez Carabante MI; Bueno D; Alonso García L; López Torija I; Marsal J; Fernandez Navarro JM; Uria Oficialdegui ML; Panesso M; Molina B; Beléndez Bieler C; Palomo P; Pérez Martínez A; Diaz-de-Heredia C
    Transplant Cell Ther; 2024 Jun; 30(6):601.e1-601.e13. PubMed ID: 38521410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
    Labrador J; López-Corral L; López-Godino O; Vázquez L; Cabrero-Calvo M; Pérez-López R; Díez-Campelo M; Sánchez-Guijo F; Pérez-López E; Guerrero C; Alberca I; Del Cañizo MC; Pérez-Simón JA; González-Porras JR; Caballero D
    Bone Marrow Transplant; 2014 May; 49(5):684-90. PubMed ID: 24566710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange.
    Xu Y; Wei Y; Wang L; Lu N; Wu Y; Dou L; Liu D; Li M; Gao C
    Ann Transplant; 2023 Jun; 28():e939890. PubMed ID: 37337423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.